Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Net Cash Flow (2023 - 2025)

Cannabis Bioscience International Holdings' Net Cash Flow history spans 3 years, with the latest figure at -$5493.0 for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 16745.45% year-over-year to -$5493.0; the TTM value through Nov 2025 reached -$97255.0, down 14702.85%, while the annual FY2025 figure was $12197.0, 249.51% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$5493.0 at Cannabis Bioscience International Holdings, up from -$103712.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $12404.0 in Q2 2025 and bottomed at -$103712.0 in Q3 2025.
  • The 3-year median for Net Cash Flow is -$246.5 (2024), against an average of -$10028.5.
  • The largest YoY upside for Net Cash Flow was 31905.13% in 2025 against a maximum downside of 48563.55% in 2025.
  • A 3-year view of Net Cash Flow shows it stood at -$4410.0 in 2023, then surged by 100.75% to $33.0 in 2024, then plummeted by 16745.45% to -$5493.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Net Cash Flow are -$5493.0 (Q4 2025), -$103712.0 (Q3 2025), and $12404.0 (Q2 2025).